Date published: 2026-4-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

Rag A Inhibitors

Rag A inhibitors belong to a class of chemical compounds that play a crucial role in the regulation of cellular processes, particularly in the context of cell growth and nutrient sensing. These inhibitors target a specific protein known as Rag A, which is a critical component of the Rag GTPase complex. The Rag GTPase complex is involved in the regulation of nutrient signaling pathways, primarily in response to amino acid availability. Rag A itself is a small GTPase protein that acts as a molecular switch, transitioning between an active GTP-bound state and an inactive GDP-bound state. The cycling between these two states is vital for the proper functioning of the complex.

Intracellular nutrient sensing is a fundamental process that allows cells to adapt their growth and metabolic activities in response to changing environmental conditions. Rag A inhibitors work by modulating the activity of Rag A, thereby influencing the nutrient signaling pathways within the cell. These inhibitors can either promote or inhibit the GTP-bound state of Rag A, depending on their specific mechanism of action. By altering the activation state of Rag A, these compounds indirectly regulate downstream processes such as mTORC1 activation, which plays a central role in controlling cell growth, protein synthesis, and autophagy.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Inhibits mTORC1, which can indirectly downregulate RRAGA activity since RRAGA is involved in mTORC1 activation.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

A PI3K inhibitor that can reduce Akt phosphorylation and subsequently influence mTORC1 activity, to which RRAGA contributes.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Another PI3K inhibitor, similarly to LY294002, it can reduce mTORC1 activity indirectly affecting RRAGA's role.

PP242

1092351-67-1sc-301606A
sc-301606
1 mg
5 mg
$57.00
$172.00
8
(1)

An mTOR kinase inhibitor that specifically targets both mTORC1 and mTORC2, thus potentially influencing RRAGA function.

AZD2014

1009298-59-2sc-364420
5 mg
$303.00
2
(0)

An ATP-competitive inhibitor of mTOR kinase, affecting both mTORC1 and mTORC2, possibly affecting RRAGA activity.

KU 0063794

938440-64-3sc-361219
10 mg
$209.00
(1)

A selective mTOR inhibitor that can influence RRAGA through inhibition of mTORC1.

INK 128

1224844-38-5sc-364511
sc-364511A
5 mg
50 mg
$321.00
$1835.00
(1)

An ATP-competitive mTOR kinase inhibitor, which can affect RRAGA function by targeting both mTOR complexes.

Zotarolimus

221877-54-9sc-213188
1 mg
$240.00
(0)

An analog of rapamycin that inhibits mTOR and can indirectly affect the activity of RRAGA.

Everolimus

159351-69-6sc-218452
sc-218452A
5 mg
50 mg
$131.00
$651.00
7
(1)

Similar to rapamycin, it is an mTOR inhibitor that can indirectly downregulate RRAGA function.

Palomid 529

914913-88-5sc-364563
sc-364563A
10 mg
50 mg
$300.00
$1000.00
(0)

A dual TORC1/TORC2 inhibitor that can indirectly affect the signaling pathway involving RRAGA.